Ape Tron Launches New Website and White Paper 6362

Ape Tron, a U.K. registered company, announced the launch of their new website and white paper at Apetron.com. Ape Tron is a Decentralized Financial (DeFi) platform, built on the Tron Blockchain and offering an interconnected eco-system of individual products, Dapps and socioeconomic experiments including the first Tron Blockchain based charting, tracking and trading tools alongside the Ape Dice Casino, Ape DeFi and Ape Swap platforms.

Ape Tron will be launching products to complement all the needs within the digital market creating an Interconnected Ecosystem of Individual Products, Dapps, and Socioeconomic Experiments. The Ape Tron White Paper explains that by developing and structuring their products, they will expand the use of the Ape Tron (APE) token to increase in its value and utility. The Ape Tron (APE) token economics are modeled to grow in value with Ape Dice, Ape DeFi, and Ape Swap. APE tokens can be used to access advanced features within the Ape Tron ecosystem and providing holders with opportunities to generate greater yield through the use of trading tools such as charting and tracking. It is expected that with the increase in the complexity of mining and the spread of the use of the Ape Tron (APE) token, its value will grow. With the expansion of the Ape Tron Ecosystem, token holders will be able to receive dividends from all projects in the APE ecosystem and participate in network governance.

With the launch of Ape Dice, token holders will be able to receive rewards from gambling Dapp profits, and with the launch of Ape DeFi and Ape Swap, receive rewards for participating in liquidity pools and mining the DeFi token. The rewards will depend on users’ share of the total value and turnover in the Ape DeFi platforms. This will incentivize users to participate in different instruments of the Ape Tron ecosystem.

To harness the power of authentic word-of-mouth and to attract more users to Ape Tron, users will be rewarded for every user they refer to the platform. The referral reward will be 10% of the number of tokens mined by referrals. The referral program will only take place during the Ape Tron (APE) and Ape DeFi (CHIMP) token mining phase.

Previous ArticleNext Article

Leave a Reply

Your email address will not be published. Required fields are marked *

Wize Pharma and Cosmos Capital enter into Bid Implementation Agreement 5440

Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, and Cosmos Capital Limited, a leading digital infrastructure provider based in Sydney, Australia, today announced that they have entered into a bid implementation agreement (“BIA”), whereby Wize has agreed to make an off-market takeover offer to acquire all of the outstanding shares of Cosmos, subject to satisfaction of various closing conditions set forth in the BIA, resulting in Cosmos becoming a wholly-owned subsidiary of Wize.

“We are excited about the Wize Cosmos transaction,” stated Noam Danenberg, CEO of Wize. “The Cosmos team brings a proven track record, experienced management and logistics capabilities within the Bitcoin mining industry. Consistent with our focus on maximising value for our shareholders, this transaction provides a continuing interest in our LO2A biomed activity, through the creation of a contingent value right, while providing exposure to Cosmos’ Bitcoin mining operations.”

James Manning, CEO and founder of Cosmos, commented, “Through this transaction we are excited to be providing public markets access to our digital infrastructure business and have enjoyed working with the like-minded Wize team throughout this process. Becoming a part of a publicly traded company is central to our continued growth and will allow us to accelerate our expansion plans moving forward.”

Key Transaction Details

Under the terms of the BIA, Wize will commence an off-market takeover offer under applicable Australian laws to acquire all of the outstanding shares of Cosmos (the “Offer”) in exchange for (i) 38.78 shares of Wize common stock and (ii) 22.33 warrants (each to acquire one share of Wize common stock) (the “Milestone Warrants”) for each Cosmos share (subject to a minimum tender of at least 90% of Cosmos’ outstanding ordinary shares). Subject to certain exceptions, the Milestone Warrants will become fully exercisable into Wize common stock provided Cosmos warrant holders retain the Wize stock issued to them until December 31, 2021 (the “31 December Milestone”).

Upon completion of the transaction, and assuming all of the holders of Cosmos shares accept the Offer, Cosmos shareholders will own approximately 81.3% of the outstanding common stock of the combined company (87% if all of the Milestone Warrants become fully vested), while Wize existing shareholders will remain the owners of approximately 16.3% of the outstanding common stock of the combined company (11.1% if all of holders of the Milestone Warrants satisfy the 31 December Milestone and the Milestone Warrants become fully vested), each on a fully diluted basis and including warrants to be issued to Wize’s financial advisor to the transaction.

Following the targeted closing of the transaction in the first quarter of 2021, and based on Wize’s 60 day VWAP of US$0.143 on December 29, 2020 (and assuming that all the Milestone Warrants become fully vested), the combined company is expected to have a market capitalisation of approximately US$75.75 million.

Upon completion of the transaction, pre-closing Wize securityholders will receive one contingent value right (“CVR”) for each share of Wize held on the record date. Each CVR will entitle the holder to a pro rata share of any consideration that may be received in connection with Wize’s existing LO2A business, subject to transaction expenses and customary deductions as detailed in the CVR agreement.

Concurrently with the execution of the BIA, Wize entered into (i) a US$3.0 million Private Investment in Public Equity (“PIPE”) financing from various accredited investors, including Noam Danenberg, CEO of Wize, in exchange for 25 million shares of common stock of Wize at US$0.12 per share, which financing is expected to close simultaneously with and subject to the closing of the Cosmos transaction, and (ii) pre-bid acceptance agreements with several Cosmos shareholders holding 19.9% of the outstanding Cosmos shares who have agreed to accept the Offer.

Following completion of the transaction, it is expected that (i) the combined company will have approximately US$5 million in cash and cash equivalents, (ii) Cosmos will retain its experienced management team, with Cosmos’ CEO and founder James Manning assuming the role of CEO of the combined company, (iii) the Board of Directors of the combined company will consist of three members designated by Cosmos and one member designated by Wize, and (iv) the combined company will seek shareholder approval to be renamed Cosmos Capital, Inc. (or similar name), and to effect a reverse share split of the combined company’s common stock.

Signify Health Projects Growth with its Partners in the BPCI Advanced Program 6338

Signify Health, a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, today announced that its provider partners in the Center for Medicare and Medicaid Innovation (CMMI) Bundled Payment for Care Improvement Advanced (BPCI-A) program have selected a larger set of bundles to participate in for the remainder of the program (2021-2023) than they did in 2020. Signify Health’s experience and feedback from providers indicate that commitment to the program remains strong.

“The world has changed a lot since 2013 when a group of providers accepted CMMI’s invitation to try a radically different approach to better coordinate care and reduce expenditures while improving the quality of that care,” said Kyle Armbrester, Signify Health CEO. “Fast forward to today and these early pioneers are leaning in and fueling the next phase of growth with new entrants, including commercial plans and employers. Thanks to CMMI’s work to lay the foundation, we have a proven model that both government and commercial payors can use to accelerate the transformation from fee-for-service to value-based care.”

As a risk-sharing convener in the BPCI-A program, Signify Health partners with Acute Care Hospitals (ACHs) and Physician Group Practices (PGPs) to facilitate collaboration among providers sharing accountability for improving outcomes. As episodes of care continue to take hold in public and private value-based health programs, Signify anticipates the total volume of medical care managed through bundles will accelerate.

In a significant change from prior years for the remainder of the BPCI-A program, CMMI required participants to select from eight categories of care, referred to as clinical service line groupings, that each include multiple bundles. Overall, Signify’s provider partners selected more clinical bundles under the new requirement, assuming a greater amount of financial risk while ensuring that patients continue to receive high-quality care.

Once bundles are selected, Signify Health’s team works with providers to prevent adverse events, improve care quality, eliminate excess cost, and propel patient recovery homeward by applying a model that addresses patients’ holistic clinical, social, and behavioral needs. And, by providing sophisticated analytics, modeling and deep local market insights, Signify supports BPCI-A participants’ care redesign efforts to improve a patient’s care journey from hospital discharge to home.

To further inform the future of episode of care payment programs in Medicare, Signify Health recently engaged Leavitt Partners to convene an independent panel of health policy experts to offer policy recommendations that strengthen and expand these models. The recommendations emanating from this advisory process will be made publicly available in the first quarter of 2021.

“For voluntary alternative payment programs to be successful, they must attract as many participants as possible,” added Armbrester. “We believe that policies that minimize uncertainty and offer pricing stability for providers accepting financial risk are critical to the program’s continued and long-term success.”

BlockApps and Schweitzer Laboratories partner to build campaign finance compliance system, 4US, restoring trust and confidence in the political financing process 6313

Campaign finance is central to the functioning of America’s democratic system, yet it is wrought with public mistrust. A 2019 Gallup study found that only 20% of Americans are satisfied with the nation’s campaign finance system. While much focus has been put on proposed adjustments to the regulatory regime through policy initiatives, little attention has been paid toward improving the existing processes of compliance and law enforcement. Schweitzer Laboratories is working with BlockApps to address these challenges by reimagining campaign finance from the inside out, using blockchain to automate the core processes of data collection, real-time compliance enforcement and transparent disclosure.

Today, political committees meet their compliance burdens through antiquated manual data collection processes and rely on expensive compliance specialists or less experienced staff and volunteers. Campaign finance regulators also struggle to meet their law enforcement and public disclosure mandates because of tight budgets, short deadlines and structural limitations. Bad data in leads to bad data out, perpetuating mistrust in a system at the heart of American democracy.

4US was created to restore that trust. Built as a multi-sided platform for all political committees and regulators, regardless of size or political affiliation, 4US improves operational efficiencies and costs, while increasing transparency. With BlockApps STRATO, 4US utilizes private chains and smart contracts to offer committees the security and privacy they demand, while improving trust and transparency in the campaign finance system overall.

“4US was created to attack one of the biggest challenges in today’s geopolitical environment, ” says Will Schweitzer, Founder and CEO of Schweitzer Laboratories. “With trust in our democratic institutions at an all-time low, political leaders can leverage 4US to show their constituents they play by the rules in a way never possible until now. Our partnership with BlockApps ensures we’re working with technologists at the bleeding edge of blockchain innovation, and that we can continue to leverage this technology to improve our society.”

“STRATO smart contracts enable Schweitzer Laboratories to encode complex processes and rules directly into 4US,” explains Kieren James-Lubin, President and CEO of BlockApps. “A private chain for each committee ensures their data will remain accurate and secure, and that it can be leveraged as a reliable and transparent record of truth when it comes time for public disclosure.”

Through this unique combination of industry and technology expertise, Schweitzer Laboratories and BlockApps are pioneering this new use case for blockchain technology. 4US exemplifies how to solve the real-world operational challenges political committees and campaign finance regulators face, while also addressing a critical societal issue.

Blockchain-Based E-Contract Startup FirmaChain Announces Partnership With ‘DTT Alliance’ 6096

South Korea based FirmaChain, a blockchain-based global electronic contract platform, announced that it has joined the DTT Alliance (Decentralized Trusted Timestamping Alliance), an alliance of blockchain-based decentralized TSA (Time Stamping Authority) and data verification companies. FirmaChain plans to work together with DTT Alliance to build a blockchain-based decentralized TSA service ecosystem and overcome the limitations of existing processes. FirmaChain is also considering collaboration with DTT Alliance partners in the future for the scalability of the blockchain network.

DTT Alliance was formed to jointly address opportunities and barriers in diverse markets of data authentication and distribution in line with the amendment of the Basic Act on Electronic Documents and E-Commerce, enactment of Three Data Bills, and the abolition of public authentication certificates in South Korea.

DTT Alliance has already confirmed participation from 15 corporates, including CJ OliveNetworks, Daebo Communication & Systems Corporation, Lotte Data Communication, Bespin Global, Busan International Film Festival, Argo, eXsoft, Initech, Xangle, Chain Partners, Topedo, Fujitsu Korea, and Hyundai AutoEver.

Shin Jae Hyuk, Secretary-General of DTT Alliance, shared, “Together with blockchain-based electronic contract platform FirmaChain, it will be possible to record and verify corporate core data including e-contracts using blockchain.”

Young Yoon, CEO of FirmaChain stated, “We hope that our participation in DTT Alliance activates the use of a more transparent blockchain-based e-contract platform like FirmaChain in the contactless and private authentication markets. Participation by various corporates in DTT Alliance will lead to the formation of a highly scalable network.”

Currently, FirmaChain is striving to expand the blockchain ecosystem by actively accepting blockchain-based technology that can be used in various industries, for example, joining MYKEEPiN ALLIANCE, one of the four major DID (Decentralized IDentifier) associations in Korea.

FirmaChain Overview

FirmaChain seeks to replace all written contracts governing social and legal issues by using an electronic contract platform based on FirmaChain’s data blockchain. Since traditional written and electronic documents are easy to forge, and the verification procedures are complicated, blockchain’s decentralization is used to solve the problem. FirmaChain can check the contract’s validity through its hash function, which can be verified in an independent node. This verification process can be used as a means to resolve legal disputes. Blockchain is an effective technology that eliminates the risk of forgery of such documents, and it is applied to the first DApp (decentralized application) of FirmaChain – the duite service.

Duite is a blockchain-based electronic contract solution that changes contracts, signatures, and management methods, focusing on solving forgery problems such as signature forgery and document falsification. The user’s contract data is encrypted using Elliptic Curve Cryptography (ECC) to guarantee the document’s security, and the encrypted document is uploaded to the server owned by FirmaChain and the InterPlanetary File System (IPFS) to ensure the safety of the user’s contract data. The double-posting security mechanism provides technically enhanced assurance that signed contract documents are kept in inviolable document storage.

The DApp implements a reliable contract-making procedure between parties. It reduces the processing cost for international contracts through contract writing using fewer resources and simplifying the process. FirmaChain is creating a service that overcomes the limitation of written contracts. Visit FirmaChain’s website https://firmachain.org/ for more information.

Insights on the Blockchain In Genomics Global Market to 2025 – Key Drivers and Challenges 7471

The “Global Blockchain In Genomics Market By Type (Public, Federated, Private), By Application (Clinical Trials, IP Management, Drug Discovery, Data storage and security, Others), By Models, By Targets, By End User, By Region, Forecast & Opportunities, 2025” report has been added to ResearchAndMarkets.com’s offering.

The Global Blockchain in Genomics Market is expected to grow at a significant CAGR during the forecast period. Blockchain in genomics stores, manages and processes the transaction of genomic data between genomic data providers and its customers. Additionally, major factor driving the market is utility and demand to secure such transactions comprising of unique genomic data. However, the market is expected to be restrained due to the lack of understanding of utility of blockchain in genomics and high maintenance costs.

The market for global blockchain in genomics is segmented based on type, application, models, targets, end-user and region. The end-user segment is bifurcated into pharmaceutical companies and research institutes. Among these, pharmaceutical companies held the dominant market share in 2019 and the trend is likely to continue in the coming years as well. Additionally, pharma companies are mainly the ones carrying out the transaction of genomic data contributing to its leading position in the market.

In terms of regional analysis, North America held the dominant share in the market because of its rich economy and the presence of numerous research companies in the region. Additionally, Asia-Pacific is anticipated to witness fastest growth until 2025 as developing economies like India and China are now adopting blockchain in genomics.

Leading players in the Global Blockchain in Genomics Market include DNAtix, Shivom, Zenome, Luna DNA, EncrypGen, Nebula Genomics, GSK, Pfizer, Genobank.io, Merck, Genomes.io, WuXi Nextcode Genomics, Murrieta Genomics, Gene Blockchain, Longenesis, SimplyVital Health, Neogen, Ripe Technology, etc. The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus increasing customer satisfaction on a global level.

Elemental to Serve Latin America and Asia with Payroll Advances, Partnering with Flash Labs 7286

Elemental.io and Flash Labs Corporation—of Big Sun Holdings Group, Inc., and a member of Hyundai BS&C family of companies—today announced a strategic partnership and joint venture to advance software development, distribution and availability of consumer credit, using financial technologies in Latin America and Asian markets. Elemental’s payroll solution, PayMachine, is an end-to-end loan origination platform focused on delivering accessible micro-loans and flexible payment options to gig workers, contractors and employees of small-, medium- and enterprise-size businesses. PayMachine is also designed to interoperate with blockchain-based payment methods—including central bank digital currency and stablecoins. This unique feature enables payment service providers (PSPs), credit unions and banks to provide currency choices above and beyond that of legacy payroll solutions, using the PayMachine brand, or a white label solution.

Flash Labs will provide software development, integration services and funding to further expand the flexibility, availability and footprint of Elemental’s payroll software solutions. The team at Flash Labs is comprised of experts in Internet of Things (IoT) and blockchain technology, creating and enhancing solutions focused on the security, sanctity and usability of data. In conjunction with its Hyundai BS&C affiliates, Flash Labs offers “best of block” blockchain development and consulting services to companies looking to integrate their hardware and software products to public or private blockchains.

“Elemental set out with a mission to bring affordable consumer credit access to the millions of employed people currently unable to access affordable credit, instead relying on payday lenders and loan sharks, who charge usury interest rates,” says Oliver Gale, Founder and CEO of Elemental. This partnership with Flash Labs will accelerate the deployment of fairer solutions for all that need them.”

The PayMachine payroll and lending solution utilizes best-in-class machine learning, credit-scoring technology and smartphone delivery of funds. Elemental, by partnering with Flash Labs, is now in a position to become the market leader in emerging market consumer credit solutions.

“Elemental’s payroll and micro-loan solutions offer a perfect platform and synergy with the services provided by Flash Labs,” says Michael Woods, CEO & COO of Flash Labs Corporation. “Our knowledge of blockchain and its ability to provide secure immutable records with excellent transaction speed will help grow Elemental’s business throughout the globe.”

Worldwide interest in alternative currency payment options for contractors, employees and gig workers continues to soar, and Elemental is already gaining traction in Latin American and Asian markets. Follow each company on social media for updates and case studies involving new opportunities for credit lending with PayMachine, a global solution for payroll and micro-lending.